10.1016/j.medmal.2013.10.002 22 CannarellaL
Further reading FcRn blockade in CIDP (ADHERE trial) The Lancet Neurology 2024 #PatientEducation #CIDP #Neuromuscular #EvidenceBasedMedicine Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial thelancet.com To view or add a comment, sign in Platelet Hyperreactivity: A Novel Peripheral Biomarker for Preclinical Alzheimers
Doctors typically recommend diabetic meds for weight loss to adults with a BMI of 30 or higher, or 27 and above with conditions like high blood pressure, cholesterol issues, or sleep apnea
In conclusion, we have designed, synthesized and validated a new ratiometric GSH sensor, TRaQ-G, which only becomes reactive in the organelle of interest
This copper-binding peptide is lyophilized to ensure maximum stability and potency for laboratory and research use
Open yourself up to a whole new world of well-being